Community-Acquired Infections Clinical Trial
— ECHOPPOfficial title:
Management of Parapneumonic Pleurisy Guided by an Early Pleural Ultrasound
NCT number | NCT04348734 |
Other study ID # | 2015-A00993-46 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 4, 2016 |
Est. completion date | May 4, 2020 |
Verified date | March 2020 |
Source | Central Hospital Saint Quentin |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Parapneumonic pleurisies are a frequent complication of pneumopathies, but therapeutic management is poorly codified. Only the indication of thoracic drainage has benefited from expert recommendations. However, we find in the literature the major importance of early management of infectious pleurisy in order to minimize the sequelae. Pleural ultrasound, sensitive and specific in this pathology could bring us a real interest in terms of diagnostic speed and therefore of care. This study therefore seeks to show that pleural ultrasound can have a major interest in improving the management of patients with parapneumonic pleurisy, by reducing the number of medical treatment failures.
Status | Completed |
Enrollment | 115 |
Est. completion date | May 4, 2020 |
Est. primary completion date | May 4, 2020 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - adult patients, hospitalized for pneumonia or confirmed pleurisy, by imaging and exploratory pleural puncture. - Patients affiliated to social security Exclusion Criteria: - patients with transudative pleurisy, - patients with exudative pleurisy in the context of pulmonary neoplasia or tuberculosis, - patients with pneumonectomy compartment infections, - Patient under guardianship or curatorship, - Subjects under 18 years of age, - Pregnant women, - patients in emergency situations |
Country | Name | City | State |
---|---|---|---|
France | Chu Amiens | Amiens | |
France | CH Pontoise | Cergy-Pontoise | |
France | CH Creteil | Créteil | |
France | Saint-Quentin Hospital | Saint-Quentin |
Lead Sponsor | Collaborator |
---|---|
Central Hospital Saint Quentin | Amiens University Hospital |
France,
Bober K, Swietlinski J. Diagnostic utility of ultrasonography for respiratory distress syndrome in neonates. Med Sci Monit. 2006 Oct;12(10):CR440-6. Epub 2006 Sep 25. — View Citation
Davies CW, Gleeson FV, Davies RJ; Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of pleural infection. Thorax. 2003 May;58 Suppl 2:ii18-28. — View Citation
Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J. 1997 May;10(5):1150-6. Review. — View Citation
LeMense GP, Strange C, Sahn SA. Empyema thoracis. Therapeutic management and outcome. Chest. 1995 Jun;107(6):1532-7. — View Citation
Lichtenstein DA, Menu Y. A bedside ultrasound sign ruling out pneumothorax in the critically ill. Lung sliding. Chest. 1995 Nov;108(5):1345-8. — View Citation
Lichtenstein DA. BLUE-protocol and FALLS-protocol: two applications of lung ultrasound in the critically ill. Chest. 2015 Jun;147(6):1659-1670. doi: 10.1378/chest.14-1313. Review. — View Citation
Light RW. Pleural diseases. Curr Opin Pulm Med. 2003 Jul;9(4):251-3. — View Citation
Miserocchi G. Physiology and pathophysiology of pleural fluid turnover. Eur Respir J. 1997 Jan;10(1):219-25. Review. — View Citation
Pothula V, Krellenstein DJ. Early aggressive surgical management of parapneumonic empyemas. Chest. 1994 Mar;105(3):832-6. — View Citation
Ramnath RR, Heller RM, Ben-Ami T, Miller MA, Campbell P, Neblett WW 3rd, Holcomb GW, Hernanz-Schulman M. Implications of early sonographic evaluation of parapneumonic effusions in children with pneumonia. Pediatrics. 1998 Jan;101(1 Pt 1):68-71. — View Citation
Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis. 1993 Sep;148(3):813-17. Review. — View Citation
Saito T, Kobayashi H, Kitamura S. Ultrasonographic approach to diagnosing chest wall tumors. Chest. 1988 Dec;94(6):1271-5. — View Citation
Soldati G, Sher S. Bedside lung ultrasound in critical care practice. Minerva Anestesiol. 2009 Sep;75(9):509-17. Review. — View Citation
Stavas J, vanSonnenberg E, Casola G, Wittich GR. Percutaneous drainage of infected and noninfected thoracic fluid collections. J Thorac Imaging. 1987 Jul;2(3):80-7. — View Citation
Taryle DA, Potts DE, Sahn SA. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest. 1978 Aug;74(2):170-3. — View Citation
Tokuda Y, Matsushima D, Stein GH, Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis. Chest. 2006 Mar;129(3):783-90. — View Citation
Xirouchaki N, Magkanas E, Vaporidi K, Kondili E, Plataki M, Patrianakos A, Akoumianaki E, Georgopoulos D. Lung ultrasound in critically ill patients: comparison with bedside chest radiography. Intensive Care Med. 2011 Sep;37(9):1488-93. doi: 10.1007/s0013 — View Citation
* Note: There are 17 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | interet de l'échographie pleurale dans les pleurésies parapneumoniques | Evaluate the failure of medical treatment, defined as the need to resort to surgery, or death secondary to pleuris | 1 year | |
Secondary | presence radiological sequelae a pleural effusion at 3 months | the presence of radiological sequelae at 3 months defined by a retraction of the hemithorax concerned with pachypleuritis or an ascent of the diaphragmatic dome or the persistence of a pleural effusion | 3 months | |
Secondary | presence radiological sequelae a pleural effusion at 6 months | the presence of radiological sequelae at 6 months defined by a retraction of the hemithorax concerned with pachypleuritis or an ascent of the diaphragmatic dome or the persistence of a pleural effusion | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01606631 -
Role of Beta-blockers in the Prevention on the Arisen of a Severe Sepsis (TESS)
|
N/A | |
Completed |
NCT02946775 -
Community Acquired Bacteremic Syndromes in Young Nigerian Children
|
||
Completed |
NCT03655548 -
Optimization Management Study of Community Urinary Tract Infections Spectrum
|
||
Completed |
NCT02531438 -
Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)
|
Phase 3 | |
Completed |
NCT00575094 -
Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects
|
Phase 3 | |
Recruiting |
NCT05047549 -
Community-based RSV Surveillance in Infant Mortality: Minimally Invasive Tissue Sampling Study in Karachi, Pakistan
|
||
Completed |
NCT00475930 -
Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates
|
N/A | |
Enrolling by invitation |
NCT03924934 -
Community-associated Highly-Resistant Enterobacterales
|
||
Recruiting |
NCT03093220 -
Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis
|
N/A | |
Not yet recruiting |
NCT03185923 -
Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe Pneumonia
|
Phase 3 | |
Not yet recruiting |
NCT06103500 -
Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis
|
N/A | |
Completed |
NCT01563315 -
Community-acquired Pneumonia in Buskerud County in Norway
|
N/A | |
Terminated |
NCT00603564 -
Helmet Continuous Positive Airway Pressure Versus Oxygen Venturi in Acute Respiratory Failure in CAP: CAPOVeRSO
|
N/A | |
Completed |
NCT00081575 -
Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia
|
Phase 3 | |
Completed |
NCT01396798 -
Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in the Paediatric A&E.
|
N/A | |
Recruiting |
NCT03379402 -
Sepsis-3 Study in Northeast Thailand
|
||
Terminated |
NCT01110421 -
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia
|
Phase 3 | |
Recruiting |
NCT03064464 -
CA-MRSA Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome
|
N/A |